BioDelivery Sciences International Inc. (NASDAQ: BDSI) Attends 31st Annual ROTH Conference
BioDelivery Sciences International (NASDAQ: BDSI) is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. BDSI is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products and those in development address serious and debilitating conditions such as chronic pain, breakthrough cancer pain, and opioid dependence. For more information, visit the company's website at www.bdsi.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial…







